FOLH1 and peripheral neuropathy: GCPII inhibitors also are analgesic in models of inflammatory and neuropathic pain [12–14] and reduce the effects of traumatic brain injury [15] while GCPII knockout (ko) mice are protected from peripheral neuropathy and ischemic and traumatic brain injury [16–18].